1369 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Shah
    Shah
  4. Sauter
    Sauter
  5. Palomba
    Palomba
  6. Goldberg
    Goldberg
  7. Halton
    Halton
  8. Brentjens
    Brentjens
  9. Chen
    Chen
  10. Moskowitz
    Moskowitz

Groups

  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)
  7. Hematologic Malignancies, Division of (327)
  8. Solid Tumor Oncology Division (324)
  9. Population Sciences Research Program (261)
  10. Biostatistics Service (257)
  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (694)
  2. Journal Article (538)
  3. Review (51)
  4. Book Section (36)
  5. Editorial (16)
  6. Research Letter (14)
  7. Miscellaneous (10)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)

More Groups

People
  1. Sergio Giralt (98)
  2. Miguel-Angel Perales (77)
  3. Gunjan Shah (68)
  4. Sean Devlin (68)
  5. Craig Sauter (63)
  6. Maria Palomba (61)

More People

Years
  1. 2025 (29)
  2. 2024 (103)
  3. 2023 (92)
  4. 2022 (114)
  5. 2021 (101)
  6. 2020 (101)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Oncology Nursing Forum (117)
  3. Blood (114)
  4. Biology of Blood and Marrow Transplantation (59)
  5. Clinical Journal of Oncology Nursing (47)
  6. Annals of Surgical Oncology (36)

More Publications

Publishers
  1. American Society of Clinical Oncology (192)
  2. Elsevier Inc. (190)
  3. Oncology Nursing Society (ONS) (169)
  4. American Society of Hematology (121)
  5. Lippincott Williams & Wilkins (91)
  6. Springer (70)

More Publishers

Results (1369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Reed, K.; Burke, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prospective study of vaginal dilator use adherence and efficacy following pelvic and intravaginal radiotherapy
    Meeting Abstract

    Law, E.; Kelvin, J. F.; Thom, B.; Riedel, E.; Tom, A.; Goodman, K. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save